Nathaniel Rothman

Personal Home Page

http://dceg.cancer.gov/about/staff-bios/rothman-nathaniel

Articles in Scholarly Journals [Incomplete List]

  1. Occupation and breast cancer risk among Shanghai women in a population-based cohort study
    American Journal of Industrial Medicine, vol. 51, no. 2, pp. 100–110, 2008
  2. Folate metabolism genes, vegetable intake and renal cancer risk in central Europe
    International Journal of Cancer, vol. 122, no. 8, pp. 1710–1715, 2008
  3. Vegetables- and antioxidant-related nutrients, genetic susceptibility, and non-Hodgkin lymphoma risk
    Cancer Causes & Control, vol. 19, no. 5, pp. 491–503, 2008
  4. Micronuclei assessment in the urothelial cells of women using hair dyes and its modulation by genetic polymorphisms
    Cancer Letters, 2008
  5. Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case–control study
    The Lancet Oncology, vol. 9, no. 4, pp. 359–366, 2008
  6. Air pollution and risk of urinary bladder cancer in a case-control study in Spain
    Occupational and Environmental Medicine, vol. 65, no. 1, pp. 56–60, 2008
  7. Menstrual and reproductive factors and gastric cancer risk in a large prospective study of women
    Gut, vol. 56, no. 12, pp. 1671–1677, 2007
  8. Genetic polymorphisms and benzene metabolism in humans exposed to a wide Range of air concentrations
    Pharmacogenetics and Genomics, vol. 17, no. 10, pp. 789–801, 2007
  9. Risk of Bladder Cancer Associated with Family History of Cancer: Do Low-Penetrance Polymorphisms Account for the Increase in Risk?
    Cancer Epidemiology Biomarkers & Prevention, vol. 16, no. 8, pp. 1595–1600, 2007
  10. Ginseng Intake and Gastric Cancer Risk in the Shanghai Women's Health Study Cohort
    Cancer Epidemiology Biomarkers & Prevention, vol. 16, no. 3, pp. 629–630, 2007
  11. Polychlorinated Biphenyls and Non-Hodgkin Lymphoma
    Cancer Epidemiology Biomarkers & Prevention, vol. 16, no. 3, pp. 373–376, 2007
  12. Bulky DNA Adduct Formation and Risk of Bladder Cancer
    Cancer Epidemiology Biomarkers & Prevention, vol. 16, no. 10, pp. 2155–2159, 2007
  13. Polymorphisms in Apoptosis and Cell Cycle Control Genes and Risk of Brain Tumors in Adults
    Cancer Epidemiology Biomarkers & Prevention, vol. 16, no. 8, pp. 1655–1661, 2007
  14. Pharmacokinetic Variability and Modern Epidemiology The Example of Dichlorodiphenyltrichloroethane, Body Mass Index, and Birth Cohort
    Cancer Epidemiology Biomarkers & Prevention, vol. 16, no. 10, pp. 1925–1930, 2007
  15. Family History of Cancer and Risk of Lung Cancer among Nonsmoking Chinese Women
    Cancer Epidemiology Biomarkers & Prevention, vol. 16, no. 11, pp. 2432–2435, 2007
  16. Flexible Design for Following Up Positive Findings
    The American Journal of Human Genetics, vol. 81, no. 3, pp. 540–551, 2007
  17. Modifications to a Standard Buccal Collection Protocol: Effects on Human DNA Yield
    Cell Preservation Technology, vol. 5, no. 4, pp. 216–224, 2007
  18. Leukocyte polycyclic aromatic hydrocarbon-DNA adduct formation and colorectal adenoma
    Carcinogenesis, vol. 28, no. 7, pp. 1426–1429, 2007
  19. Hair dye use, genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma
    Carcinogenesis, vol. 28, no. 8, pp. 1759–1764, 2007
  20. Evaluation of genetic variation in the double-strand break repair pathway and bladder cancer risk
    Carcinogenesis, vol. 28, no. 8, pp. 1788–1793, 2007
  21. Food, nutrient and heterocyclic amine intake and the risk of bladder cancer
    European Journal of Cancer, vol. 43, no. 11, pp. 1731–1740, 2007
  22. Genetic variation in the base excision repair pathway and bladder cancer risk
    Human Genetics, vol. 121, no. 2, pp. 233–242, 2007
  23. One-carbon metabolism gene polymorphisms and risk of non-Hodgkin lymphoma in Australia
    Human Genetics, vol. 122, no. 5, pp. 525–533, 2007
  24. Sun exposure, vitamin D receptor gene polymorphisms and risk of non-Hodgkin lymphoma
    Cancer Causes & Control, vol. 18, no. 9, pp. 989–999, 2007
  25. Measurement of urine pH for epidemiological studies on bladder cancer
    European Journal of Epidemiology, vol. 22, no. 2, pp. 91–98, 2007
  26. Genotype frequency and F ST analysis of polymorphisms in immunoregulatory genes in Chinese and Caucasian populations
    Immunogenetics, vol. 59, no. 11, pp. 839–852, 2007
  27. Occupation and adult-onset asthma among chinese women in a population-based cohort
    American Journal of Industrial Medicine, vol. 50, no. 4, pp. 265–273, 2007
  28. Aberrations in chromosomes associated with lymphoma and therapy-related leukemia in benzene-exposed workers
    Environmental and Molecular Mutagenesis, vol. 48, no. 6, pp. 467–474, 2007
  29. Polymorphisms in one-carbon metabolism and trans-sulfuration pathway genes and susceptibility to bladder cancer
    International Journal of Cancer, vol. 120, no. 11, pp. 2452–2458, 2007
  30. Common variants in genes that mediate immunity and risk of multiple myeloma
    International Journal of Cancer, vol. 120, no. 12, pp. 2715–2722, 2007
  31. Reply to the letter to the Editor: “N-Acetyltransferases and the susceptibility to benzidine-induced bladder carcinogenesis”
    International Journal of Cancer, vol. 121, no. 7, pp. 1637–1639, 2007
  32. Polychlorinated Biphenyl Levels in Peripheral Blood and Non-Hodgkin's Lymphoma: A Report from Three Cohorts
    Cancer Research, vol. 67, no. 11, pp. 5545–5552, 2007
  33. Immune Mechanisms in Non-Hodgkin Lymphoma: Joint Effects of the TNF G308A and IL10 T3575A Polymorphisms with Non-Hodgkin Lymphoma Risk Factors
    Cancer Research, vol. 67, no. 10, pp. 5042–5054, 2007
  34. Large-Scale Evaluation of Candidate Genes Identifies Associations between VEGF Polymorphisms and Bladder Cancer Risk
    PLoS Genetics, vol. 3, no. 2, p. e29, 2007
  35. Vitamin D receptor gene polymorphisms and risk of non-Hodgkin's lymphoma
    Haematologica, vol. 92, no. 8, pp. 1145–1146, 2007
  36. Polymorphisms in DNA repair genes and risk of non-Hodgkin's lymphoma in New South Wales, Australia
    Haematologica, vol. 92, no. 9, pp. 1180–1185, 2007
  37. Impact of interleukin-10 polymorphisms ( 1082 and 3575) on the survival of patients with lymphoid neoplasms
    Haematologica, vol. 92, no. 11, pp. 1475–1481, 2007
  38. Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival
    Blood, vol. 109, no. 12, pp. 5439–5446, 2007
  39. NHL and genomic variability in RAG1 and BRCA2
    Blood, vol. 109, no. 12, pp. 5523–5523, 2007
  40. Albumin Adducts of Electrophilic Benzene Metabolites in Benzene-Exposed and Control Workers
    Environmental Health Perspectives, 2006
  41. Prospective Study of Urinary Prostaglandin E2 Metabolite and Colorectal Cancer Risk
    Journal of Clinical Oncology, vol. 24, no. 31, pp. 5010–5016, 2006
  42. Variation in genes relevant to aromatic hydrocarbon metabolism and the risk of adult brain tumors
    Neuro-Oncology, vol. 8, no. 2, pp. 145–155, 2006
  43. Polymorphisms in DNA repair genes and risk of non-Hodgkin lymphoma among women in Connecticut
    Human Genetics, vol. 119, no. 6, pp. 659–668, 2006
  44. Cyclin D1 splice variant and risk for non-Hodgkin lymphoma
    Human Genetics, vol. 120, no. 2, pp. 297–300, 2006
  45. Hair dye use is not associated with risk for bladder cancer: Evidence from a case-control study in Spain
    European Journal of Cancer, vol. 42, no. 10, pp. 1448–1454, 2006
  46. Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium
    The Lancet Oncology, vol. 7, no. 1, pp. 27–38, 2006
  47. Assessment of dermal exposure to benzene and toluene in shoe manufacturing by activated carbon cloth patches
    Journal of Environmental Monitoring, vol. 8, no. 11, p. 1143, 2006
  48. Polymorphisms in oxidative stress genes and risk for non-Hodgkin lymphoma
    Carcinogenesis, vol. 27, no. 9, pp. 1828–1834, 2006
  49. Polymorphisms in genes involved in DNA double-strand break repair pathway and susceptibility to benzene-induced hematotoxicity
    Carcinogenesis, vol. 27, no. 10, pp. 2083–2089, 2006
  50. Genetic variants in caspase genes and susceptibility to non-Hodgkin lymphoma
    Carcinogenesis, vol. 28, no. 4, pp. 823–827, 2006
  51. Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: findings from the New South Wales non-Hodgkin Lymphoma Study
    Carcinogenesis, vol. 28, no. 3, pp. 704–712, 2006
  52. Commentary: Reflections on G. M. Lower and colleagues' 1979 study associating slow acetylator phenotype with urinary bladder cancer: meta-analysis, historical refinements of the hypothesis, and lessons learned
    International Journal of Epidemiology, vol. 36, no. 1, pp. 23–28, 2006
  53. Evidence for an intensity-dependent interaction of NAT2 acetylation genotype and cigarette smoking in the Spanish Bladder Cancer Study
    International Journal of Epidemiology, vol. 36, no. 1, pp. 236–241, 2006
  54. Cancer Survivorship--Genetic Susceptibility and Second Primary Cancers: Research Strategies and Recommendations
    CancerSpectrum Knowledge Environment, vol. 98, no. 1, pp. 15–25, 2006
  55. Bladder Cancer and Exposure to Water Disinfection By-Products through Ingestion, Bathing, Showering, and Swimming in Pools
    American Journal of Epidemiology, vol. 165, no. 2, pp. 148–156, 2006
  56. Risk of non-Hodgkin lymphoma (NHL) in relation to germline variation in DNA repair and related genes
    Blood, vol. 108, no. 9, pp. 3161–3167, 2006
  57. Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma
    Blood, vol. 107, no. 10, pp. 4101–4108, 2006
  58. Gene-nutrient interactions among determinants of folate and one-carbon metabolism on the risk of non-Hodgkin lymphoma: NCI-SEER Case-Control Study
    Blood, 2006
  59. Genetic Variation in the Nucleotide Excision Repair Pathway and Bladder Cancer Risk
    Cancer Epidemiology Biomarkers & Prevention, vol. 15, no. 3, pp. 536–542, 2006
  60. Smoking and Bladder Cancer in Spain: Effects of Tobacco Type, Timing, Environmental Tobacco Smoke, and Gender
    Cancer Epidemiology Biomarkers & Prevention, vol. 15, no. 7, pp. 1348–1354, 2006
  61. Use of Analgesics and Nonsteroidal Anti-inflammatory Drugs, Genetic Predisposition, and Bladder Cancer Risk in Spain
    Cancer Epidemiology Biomarkers & Prevention, vol. 15, no. 9, pp. 1696–1702, 2006
  62. Inflammation-Related Gene Polymorphisms and Colorectal Adenoma
    Cancer Epidemiology Biomarkers & Prevention, vol. 15, no. 6, pp. 1126–1131, 2006
  63. Metabolic Gene Variants and Risk of Non-Hodgkin's Lymphoma
    Cancer Epidemiology Biomarkers & Prevention, vol. 15, no. 9, pp. 1647–1653, 2006
  64. Modeling Human Metabolism of Benzene Following Occupational and Environmental Exposures
    Cancer Epidemiology Biomarkers & Prevention, vol. 15, no. 11, pp. 2246–2252, 2006
  65. Interleukin-6-Related Genotypes, Body Mass Index, and Risk of Multiple Myeloma and Plasmacytoma
    Cancer Epidemiology Biomarkers & Prevention, vol. 15, no. 11, pp. 2285–2291, 2006
  66. Lead, Genetic Susceptibility, and Risk of Adult Brain Tumors
    Cancer Epidemiology Biomarkers & Prevention, vol. 15, no. 12, pp. 2514–2520, 2006
  67. Physiologically-Based Pharmacokinetic Modeling of Benzene in Humans: A Bayesian Approach
    Risk Analysis, vol. 26, no. 4, pp. 925–943, 2006
  68. Common Genetic Variants in Proinflammatory and Other Immunoregulatory Genes and Risk for Non-Hodgkin Lymphoma
    Cancer Research, vol. 66, no. 19, pp. 9771–9780, 2006
  69. Genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2) and risk of non-Hodgkin lymphoma
    Pharmacogenetics and Genomics, vol. 16, no. 8, pp. 537–545, 2006
  70. Organochlorines in Carpet Dust and Non-Hodgkin Lymphoma
    Epidemiology, vol. 16, no. 4, pp. 516–525, 2005
  71. A Putative Exonic Splicing Polymorphism in the BCL6 Gene and the Risk of Non-Hodgkin Lymphoma
    CancerSpectrum Knowledge Environment, vol. 97, no. 21, pp. 1616–1618, 2005
  72. Polymorphisms in Cytokine and Cellular Adhesion Molecule Genes and Susceptibility to Hematotoxicity among Workers Exposed to Benzene
    Cancer Research, vol. 65, no. 20, pp. 9574–9581, 2005
  73. Persistent Organochlorine Chemicals in Plasma and Risk of Non-Hodgkin's Lymphoma
    Cancer Research, vol. 65, no. 23, pp. 11214–11226, 2005
  74. The Shanghai Women's Health Study: Rationale, Study Design, and Baseline Characteristics
    American Journal of Epidemiology, vol. 162, no. 11, pp. 1123–1131, 2005
  75. Selected DNA repair polymorphisms and gastric cancer in Poland
    Carcinogenesis, vol. 26, no. 8, pp. 1354–1359, 2005
  76. Using urinary biomarkers to elucidate dose-related patterns of human benzene metabolism
    Carcinogenesis, vol. 27, no. 4, pp. 772–781, 2005
  77. Hemoglobin adducts in workers exposed to benzidine and azo dyes
    Carcinogenesis, vol. 27, no. 8, pp. 1600–1606, 2005
  78. Decreased levels of CXC-chemokines in serum of benzene-exposed workers identified by array-based proteomics
    Proceedings of the National Academy of Sciences, vol. 102, no. 47, pp. 17041–17046, 2005
  79. slow acetylation, null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses
    The Lancet, vol. 366, no. 9486, pp. 649–659, 2005
  80. Green tea consumption, genetic susceptibility, PAH-rich smoky coal, and the risk of lung cancer
    Mutation Research/Genetic Toxicology and Environmental Mutagenesis, vol. 582, no. 1-2, pp. 53–60, 2005
  81. No apparent association between genetic polymorphisms (?102 C>T) and (?9 T>C) in the human manganese superoxide dismutase gene and gastric cancer
    Journal of Surgical Research, vol. 124, no. 1, pp. 92–97, 2005
  82. Polymorphisms in folate metabolic genes and lung cancer risk in Xuan Wei, China
    Lung Cancer, vol. 49, no. 3, pp. 299–309, 2005
  83. Methods for etiologic and early marker investigations in the PLCO trial
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 592, no. 1-2, pp. 147–154, 2005
  84. Mortality among Participants in the Agricultural Health Study
    Annals of Epidemiology, vol. 15, no. 4, pp. 279–285, 2005
  85. Protein adducts as biomarkers of human benzene metabolism
    Chemico-Biological Interactions, vol. 153-154, pp. 103–109, 2005
  86. Lymphocyte toxicity and T cell receptor excision circles in workers exposed to benzene
    Chemico-Biological Interactions, vol. 153-154, pp. 111–115, 2005
  87. Use of OctoChrome fluorescence in situ hybridization to detect specific aneuploidy among all 24 chromosomes in benzene-exposed workers
    Chemico-Biological Interactions, vol. 153-154, pp. 117–122, 2005
  88. Use of ‘Omic’ technologies to study humans exposed to benzene
    Chemico-Biological Interactions, vol. 153-154, pp. 123–127, 2005
  89. Comparison of yield and genotyping performance of multiple displacement amplification and OmniPlex™ whole genome amplified DNA generated from multiple DNA sources
    Human Mutation, vol. 26, no. 3, pp. 262–270, 2005
  90. Polymorphisms in the DNA nucleotide excision repair genes and lung cancer risk in Xuan Wei, China
    International Journal of Cancer, vol. 116, no. 5, pp. 768–773, 2005
  91. NAT2 slow acetylation and bladder cancer in workers exposed to benzidine
    International Journal of Cancer, vol. 118, no. 1, pp. 161–168, 2005
  92. Discovery of Novel Biomarkers by Microarray Analysis of Peripheral Blood Mononuclear Cell Gene Expression in Benzene-Exposed Workers
    Environmental Health Perspectives, 2005
  93. Delta-Aminolevulinic Acid Dehydratase Polymorphism and Risk of Brain Tumors in Adults
    Environmental Health Perspectives, 2005
  94. Genetic Polymorphisms of CYP2E1, GSTT1, GSTP1, GSTM1, ALDH2, and ODC and the Risk of Advanced Precancerous Gastric Lesions in a Chinese Population
    Cancer Epidemiology Biomarkers & Prevention, vol. 14, no. 2, pp. 451–458, 2005
  95. Dietary Intake of Heterocyclic Amines and Benzo(a)Pyrene: Associations with Pancreatic Cancer
    Cancer Epidemiology Biomarkers & Prevention, vol. 14, no. 9, pp. 2261–2265, 2005
  96. Dietary Benzo[a]Pyrene Intake and Risk of Colorectal Adenoma
    Cancer Epidemiology Biomarkers & Prevention, vol. 14, no. 8, pp. 2030–2034, 2005
  97. Genetic Variation and Willingness to Participate in Epidemiologic Research: Data from Three Studies
    Cancer Epidemiology Biomarkers & Prevention, vol. 14, no. 10, pp. 2449–2453, 2005
  98. BMC Genetics, vol. 5, no. 1, p. 33, 2004
  99. Urinary mutagenesis and fried red meat intake: Influence of cooking temperature, phenotype, and genotype of metabolizing enzymes in a controlled feeding study
    Environmental and Molecular Mutagenesis, vol. 43, no. 1, pp. 53–74, 2004
  100. Rapid determination of six urinary benzene metabolites in occupationally exposed and unexposed subjects
    Analytical Biochemistry, vol. 327, no. 2, pp. 184–199, 2004
  101. Lack of increased genetic damage in 1,3-butadiene-exposed Chinese workers studied in relation to EPHX1 and GST genotypes
    Mutation Research/Genetic Toxicology and Environmental Mutagenesis, vol. 558, no. 1-2, pp. 63–74, 2004
  102. Detailed Exposure Assessment for a Molecular Epidemiology Study of Benzene in Two Shoe Factories in China
    Annals of Occupational Hygiene, vol. 48, no. 2, pp. 105–116, 2004
  103. Diet and Nutrient Intakes and Risk of Non-Hodgkin's Lymphoma in Connecticut Women
    American Journal of Epidemiology, vol. 159, no. 5, pp. 454–466, 2004
  104. Assessing the Probability That a Positive Report is False: An Approach for Molecular Epidemiology Studies
    CancerSpectrum Knowledge Environment, vol. 96, no. 6, pp. 434–442, 2004
  105. Re: Assessing the Probability That a Positive Report is False: An Approach for Molecular Epidemiology Studies
    CancerSpectrum Knowledge Environment, vol. 96, no. 22, pp. 1722–1722, 2004
  106. Oxidative damage-related genes AKR1C3 and OGG1 modulate risks for lung cancer due to exposure to PAH-rich coal combustion emissions
    Carcinogenesis, vol. 25, no. 11, pp. 2177–2181, 2004
  107. Hematotoxicity in Workers Exposed to Low Levels of Benzene
    Science, vol. 306, no. 5702, pp. 1774–1776, 2004
  108. Effects of Electron-Beam Irradiation on Buccal-Cell DNA
    The American Journal of Human Genetics, vol. 73, no. 3, pp. 646–651, 2003
  109. Insulin-like Growth Factor I, Insulin-like Growth Factor Binding Protein 3, and Urologic Measures of Benign Prostatic Hyperplasia
    American Journal of Epidemiology, vol. 157, no. 9, pp. 784–791, 2003
  110. Pooled Analysis and Meta-analysis of Glutathione S-Transferase M1 and Bladder Cancer: A HuGE Review
    American Journal of Epidemiology, vol. 156, no. 2, pp. 95–109, 2002
  111. A Quantitative Approach for Estimating Exposure to Pesticides in the Agricultural Health Study
    Annals of Occupational Hygiene, vol. 46, no. 2, pp. 245–260, 2002
  112. Highly sensitive chemiluminescence immunoassay for benzo[a]pyrene-DNA adducts: validation by comparison with other methods, and use in human biomonitoring
    Carcinogenesis, vol. 23, no. 12, pp. 2043–2049, 2002
  113. Genetic polymorphisms in heterocyclic amine metabolism and risk of colorectal adenomas
    Pharmacogenetics, vol. 12, no. 2, pp. 145–150, 2002
  114. Metabolites of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine (PhIP) in human urine after consumption of charbroiled or fried beef
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 506-507, pp. 163–173, 2002
  115. Study of genes and environmental factors in complex diseases
    The Lancet, vol. 359, no. 9312, pp. 1155–1155, 2002
  116. Combined effect of glutathione S-transferase M1 and T1 genotypes on bladder cancer risk
    Cancer Letters, vol. 177, no. 2, pp. 173–179, 2002
  117. Non-linear production of benzene oxide–albumin adducts with human exposure to benzene
    Journal of Chromatography B, vol. 778, no. 1-2, pp. 367–374, 2002
  118. Micronucleus frequency and proliferation in human lymphocytes after exposure to herbicide 2,4-dichlorophenoxyacetic acid in vitro and in vivo
    Mutation Research/Genetic Toxicology and Environmental Mutagenesis, vol. 521, no. 1-2, pp. 165–178, 2002
  119. Urothelial cell DNA adducts in rubber workers
    Environmental and Molecular Mutagenesis, vol. 39, no. 4, pp. 306–313, 2002
  120. Concentration of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine (PhIP) in urine and alkali-hydrolyzed urine after consumption of charbroiled beef
    Cancer Letters, vol. 173, no. 1, pp. 43–51, 2001
  121. Nature, vol. 412, no. 6842, pp. 99–99, 2001
  122. Measurement of 2-amino-1-methyl-6-phenylimidazo(4,5- b )pyridine (PhIP) in acid-hydrolyzed urine by high-performance liquid chromatography with fluorescence detection
    Biomarkers, vol. 6, no. 5, pp. 313–325, 2001
  123. High urine 1-hydroxypyrene glucuronide concentrations in Linxian, China, an area of high risk for squamous oesophageal cancer
    Biomarkers, vol. 6, no. 5, pp. 381–386, 2001
  124. Glutathione S-transferase genotypes and stomach cancer in a population-based case???control study in Warsaw, Poland
    Pharmacogenetics, vol. 11, no. 8, pp. 655–661, 2001
  125. p53 Gene Expression in Relation to Indoor Exposure to Unvented Coal Smoke in Xuan Wei, China
    Journal of Occupational and Environmental Medicine, vol. 43, no. 3, pp. 226–230, 2001
  126. Urinary benzene as a biomarker of exposure among occupationally exposed and unexposed subjects
    Carcinogenesis, vol. 22, no. 2, pp. 279–286, 2001
  127. Agricultural risk factors for t(14;18) subtypes of non-Hodgkin???s lymphoma
    Epidemiology, vol. 12, no. 6, pp. 701–709, 2001
  128. Pharmacogenetics, vol. 10, no. 2, pp. 115–122, 2000
  129. Population Stratification in Epidemiologic Studies of Common Genetic Variants and Cancer: Quantification of Bias
    Journal of the National Cancer Institute, vol. 92, no. 14, pp. 1151–1158, 2000
  130. Comparing odds ratios for nested subsets of dietary components
    International Journal of Epidemiology, vol. 29, no. 6, pp. 1060–1064, 2000
  131. BENZENE AND LYMPHOHEMATOPOIETIC MALIGNANCIES IN CHINA
    Journal of Toxicology and Environmental Health Part A, vol. 61, no. 5-6, pp. 419–432, 2000
  132. BIOMARKERS IN THE MOLECULAR EPIDEMIOLOGY OF BENZENE-EXPOSED WORKERS
    Journal of Toxicology and Environmental Health Part A, vol. 61, no. 5-6, pp. 439–445, 2000
  133. Cancer Causes and Control, vol. 11, no. 4, pp. 373–380, 2000
  134. Interleukin-1 polymorphisms associated with increased risk of gastric cancer
    Nature, vol. 404, no. 6776, Article ID 35006081, 4 pages, 2000
  135. Cancer Causes & Control, vol. 10, no. 1, pp. 1–11, 1999
  136. Polycyclic Aromatic Hydrocarbon Biomarkers of Internal Exposure in U.S. Army Soldiers Serving in Kuwait in 1991
    Polycyclic Aromatic Compounds, vol. 17, no. 1, pp. 197–208, 1999
  137. Role of well-done, grilled red meat, heterocyclic amines (HCAs) in the etiology of human cancer
    Cancer Letters, vol. 143, no. 2, pp. 189–194, 1999
  138. Benzene increases aneuploidy in the lymphocytes of exposed workers: A comparison of data obtained by fluorescence in situ hybridization in interphase and metaphase cells
    Environmental and Molecular Mutagenesis, vol. 34, no. 4, pp. 260–268, 1999
  139. Journal of Agricultural and Food Chemistry, vol. 46, no. 11, pp. 4648–4651, 1998
  140. Cancer Causes and Control, vol. 9, no. 4, pp. 417–424, 1998
  141. Increased aneusomy and long arm deletion of chromosomes 5 and 7 in the lymphocytes of Chinese workers exposed to benzene
    Carcinogenesis, vol. 19, no. 11, pp. 1955–1961, 1998
  142. Hemoglobin and albumin adducts of benzene oxide among workers exposed to high levels of benzene
    Carcinogenesis, vol. 19, no. 9, pp. 1565–1571, 1998
  143. Urinary mutagenicity as a biomarker in workers exposed to benzidine: correlation with urinary metabolites and urothelial DNA adducts
    Carcinogenesis, vol. 18, no. 5, pp. 981–988, 1997
  144. Benzene and the dose-related incidence of hematologic neoplasms in China. Chinese Academy of Preventive Medicine--National Cancer Institute Benzene Study Group
    Journal of the National Cancer Institute, vol. 89, no. 14, pp. 1065–1071, 1997
  145. Validation of Benzene Exposure Assessment
    Annals of the New York Academy of Sciences, vol. 837, no. 1, pp. 114–121, 1997
  146. Investigation of Ornithine Decarboxylase Activity and Two-Dimensional Electrophoretic Protein Profile Following Exposure of T24 Bladder Carcinoma Cells to Tumor Promoter and Carcinogen
    Toxicology Methods, vol. 7, no. 1, pp. 27–41, 1997
  147. Interindividual variation in the levels of certain urinary polycyclic aromatic hydrocarbon metabolites following medicinal exposure to coal tar ointment
    Biomarkers, vol. 2, no. 5, pp. 321–327, 1997
  148. Association of 1 hydroxypyrene glucuronide in human urine with cigarette smoking and broiled or roasted meat consumption
    Biomarkers, vol. 2, no. 4, pp. 217–221, 1997
  149. A nested case-control study of non-Hodgkin lymphoma and serum organochlorine residues
    The Lancet, vol. 350, no. 9073, pp. 240–244, 1997
  150. Benzidine–DNA adduct levels in human peripheral white blood cells significantly correlate with levels in exfoliated urothelial cells
    Mutation Research/Genetic Toxicology and Environmental Mutagenesis, vol. 393, no. 3, pp. 199–205, 1997
  151. Exposure assessment of heterocyclic amines (HCAs) in epidemiologic studies
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 376, no. 1-2, pp. 195–202, 1997
  152. The agricultural health study: Factors affecting completion and return of self-administered questionnaires in a large prospective cohort study of pesticide applicators
    American Journal of Industrial Medicine, vol. 31, no. 2, pp. 233–242, 1997
  153. Risk of adenocarcinoma of the stomach and esophagus with meat cooking method and doneness preference
    International Journal of Cancer, vol. 71, no. 1, pp. 14–19, 1997
  154. Hematotoxocity among Chinese workers heavily exposed to benzene
    American Journal of Industrial Medicine, vol. 29, no. 3, pp. 236–246, 1996
  155. Determination of Benzidine,N-Acetylbenzidine, andN,N'-Diacetylbenzidine in Human Urine by Capillary Gas Chromatography/Negative Ion Chemical Ionization Mass Spectrometry
    Analytical Biochemistry, vol. 234, no. 2, pp. 183–189, 1996
  156. Genetic susceptibility biomarkers in studies of occupational and environmental cancer: methodologic issues
    Toxicology Letters, vol. 77, no. 1-3, pp. 221–225, 1995
  157. Polypyrrole-bearing conductive composite prepared by an inverted emulsion pathway involving nonionic surfactants
    Synthetic Metals, vol. 72, no. 3, pp. 261–267, 1995
  158. Benzene Induces Gene-Duplicating but not Gene-Inactivating Mutations at the Glycophorin A Locus in Exposed Humans
    Proceedings of the National Academy of Sciences, vol. 92, no. 9, pp. 4069–4073, 1995
  159. Cancer and Noncancer Risk to Women in Agriculture and Pest Control:The Agricultural Health Study
    Journal of Occupational and Environmental Medicine, vol. 36, no. 11, pp. 1247–1250, 1994
  160. OCCUPATIONAL EXPOSURES IN CALIFORNIA WILDLAND FIRE FIGHTING
    AIHA Journal, vol. 53, no. 1, pp. 69–76, 1992
  161. Acute high dose exposure to benzene in shipyard workers
    American Journal of Industrial Medicine, vol. 22, no. 4, pp. 553–565, 1992
  162. Pulmonary Function and Respiratory Symptoms in Wildland Firefighters
    Journal of Occupational and Environmental Medicine, vol. 33, no. 11, pp. 1163–1167, 1991
  163. Solvent-associated decrements in olfactory function in paint manufacturing workers
    American Journal of Industrial Medicine, vol. 18, no. 6, pp. 697–706, 1990